Literature DB >> 17931362

Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo.

Gwen McCaffrey1, William D Staatz, Carolyn A Quigley, Nicole Nametz, Melissa J Seelbach, Chris R Campos, Tracy A Brooks, Richard D Egleton, Thomas P Davis.   

Abstract

Tight junctions (TJs) are major components of the blood-brain barrier (BBB) that physically obstruct the interendothelial space and restrict paracellular diffusion of blood-borne substances from the peripheral circulation to the CNS. TJs are dynamic structures whose intricate arrangement of oligomeric transmembrane and accessory proteins rapidly alters in response to external stressors to produce changes in BBB permeability. In this study, we investigate the constitutive trafficking of the TJ transmembrane proteins occludin and claudin-5 that are essential for forming the TJ seal between microvascular endothelial cells that inhibits paracellular diffusion. Using a novel, detergent-free OptiPrep density-gradient method to fractionate rat cerebral microvessels, we identify a plasma membrane lipid raft domain that contains oligomeric occludin and claudin-5. Our data suggest that oligomerization of occludin involves disulfide bond formation within transmembrane regions, and that assembly of the TJ oligomeric protein complex is facilitated by an oligomeric caveolin scaffold. This is the first time that distribution of oligomeric TJ transmembrane proteins within plasma membrane lipid rafts at the BBB has been examined in vivo. The findings reported in this study are critical to understand the mechanism of assembly of the TJ multiprotein complex that is essential for maintaining BBB integrity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17931362     DOI: 10.1111/j.1471-4159.2007.04943.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  55 in total

Review 1.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

2.  CRM197-induced blood-brain barrier permeability increase is mediated by upregulation of caveolin-1 protein.

Authors:  Ping Wang; Yunhui Liu; Xiuli Shang; Yixue Xue
Journal:  J Mol Neurosci       Date:  2010-11-16       Impact factor: 3.444

Review 3.  Apicobasal polarity of brain endothelial cells.

Authors:  Thomas Worzfeld; Markus Schwaninger
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-06       Impact factor: 6.200

Review 4.  Reactive oxygen species in inflammation and tissue injury.

Authors:  Manish Mittal; Mohammad Rizwan Siddiqui; Khiem Tran; Sekhar P Reddy; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2013-10-22       Impact factor: 8.401

5.  Identification of P-glycoprotein co-fractionating proteins and specific binding partners in rat brain microvessels.

Authors:  Margaret E Tome; Charles P Schaefer; Leigh M Jacobs; Yifeng Zhang; Joseph M Herndon; Fabian O Matty; Thomas P Davis
Journal:  J Neurochem       Date:  2015-04-21       Impact factor: 5.372

6.  Bacillus cereus-induced permeability of the blood-ocular barrier during experimental endophthalmitis.

Authors:  Andrea L Moyer; Raniyah T Ramadan; Billy D Novosad; Roger Astley; Michelle C Callegan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-05       Impact factor: 4.799

Review 7.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 8.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

9.  Vascular neural network phenotypic transformation after traumatic injury: potential role in long-term sequelae.

Authors:  J Badaut; G J Bix
Journal:  Transl Stroke Res       Date:  2013-11-29       Impact factor: 6.829

Review 10.  Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development.

Authors:  Beatriz Rodriguez-Grande; Aleksandra Ichkova; Sighild Lemarchant; Jerome Badaut
Journal:  AAPS J       Date:  2017-09-13       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.